Skip to content
Gold Mining News – Lifestyle
Home
Sample Page
Author:
EIT Pharma
EIT Pharma Announces FDA Acceptance of New Drug Application for Lonafarnib for Treatment of Chronic Hepatitis D
August 11, 2026
EIT Pharma Highlights New Lonafarnib Analyses at EASL Congress 2026
June 1, 2026